There are 2789 resources available
1640P - Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)
Presenter: Daniela Tregnago
Session: ePoster Display
1650P - Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Presenter: David Chun Cheong Tsui
Session: ePoster Display
1651P - Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Toshiaki Takahashi
Session: ePoster Display
1735P - Circulating T-cell immunosenescence in patients with thymic epithelial tumors (TETs)
Presenter: Jose Carlos Benitez Montanez
Session: ePoster Display
1653P - Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
Presenter: Maria A Papadaki
Session: ePoster Display
1646TiP - Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
Presenter: Rodolfo Passalacqua
Session: ePoster Display
1655P - Real-world outcome of patients with relapsed or refractory small cell lung cancer treated with checkpoint inhibitors in Tertiary Care Centers across Germany
Presenter: Jan Stratmann
Session: ePoster Display
1656P - Germline mutations in DNA damage repair genes in patients with small cell lung cancer
Presenter: Yu Feng
Session: ePoster Display
1657P - Anlotinib plus irinotecan or docetaxel in small-cell lung cancer (SCLC) relapsed within six months: Updated results from a single-arm phase II study
Presenter: Bing Xia
Session: ePoster Display
1741P - Malignant effusion-derived non-small cell lung cancer organoid might be a feasible in vitro model for therapeutic screening
Presenter: Han-Min Wang
Session: ePoster Display